Can I have my mitochondrial function measured with a blood test from the internet?

Not reliably. There is no single validated laboratory value that captures mitochondrial function as an overall measure. Commercial tests mostly measure non-specific markers whose individual informative value is not established. Without a medical question and standardized sampling, individual values are barely interpretable.

Does a normal lactate value mean my mitochondria are healthy?

No. In the diagnosis of primary mitochondrial diseases, lactate has only a moderate sensitivity (according to specialist consensus around 34–62 %). A normal value does not rule out a disorder, and small elevations should not be over-interpreted. Respiratory chain enzyme findings can also come out falsely normal.

What is the benchmark in mitochondrial diagnostics today?

Genetic (molecular) diagnostics. Clinics have shifted from a "biopsy-first" to a "gene-first" approach. Biomarkers such as GDF-15 and FGF-21 and, where appropriate, a muscle biopsy complement the evaluation, but do not replace the genetic investigation.

Diagnostics7 min readLast reviewed: June 2026

Measuring Mitochondrial Function: What Research and Clinics Actually Investigate

Mitochondria are the powerhouses of the cell: they convert nutrients and oxygen into usable energy. A natural question follows — can you simply measure "mitochondrial function"? — and indeed a growing number of providers advertise tests that promise exactly that. The honest answer is more complicated: in the clinical diagnosis of primary mitochondrial diseases there are established procedures, but no single test that reliably and comprehensively captures mitochondrial function. This article explains which methods research and clinics use, what they reveal — and where the limits of commercial offerings lie. It is no substitute for medical evaluation; if a metabolic disease is genuinely suspected, specialist diagnostics are the right path.

Machine-assisted translation. The German original is the authoritative version.

Key points

There is no single test that reliably and comprehensively captures "mitochondrial function" — clinical diagnostics always combines several building blocks.
Established procedures range from blood and urine markers (lactate, organic acids) through exercise tests and imaging to muscle biopsy and — in research — direct respiration measurement.
Newer markers such as GDF-15 and FGF-21 are the most informative, but they too are not perfect; genetic diagnostics remains the benchmark.
Normal findings do not reliably rule out a disorder, and small lactate elevations must not be overvalued — context and standardization are decisive.
Commercial "mitochondria checks" cannot deliver on their claim according to current knowledge; if there is genuine suspicion, medical evaluation is the right path.

What mitochondria do — and why they are hard to measure

Through the so-called respiratory chain (complexes I to IV plus ATP synthase), mitochondria generate most of the cell's energy in the form of ATP. If this process is disrupted, it can affect many organs, above all those with high energy demand: the brain, muscles, heart and eyes. It is precisely this diversity that is the core diagnostic problem.

There is no single "mitochondrial function" that could be read off like blood sugar. Function is tissue-specific, fluctuates with exertion and rest, and may be impaired in one organ while appearing normal in others. In genetically caused mitochondrial diseases, the unclear genotype–phenotype relationship further complicates interpretation — identical mutations can produce very different clinical pictures. That is why clinics usually combine several building blocks rather than relying on a single measured value.

Through the respiratory chain, mitochondria supply most of the cell's energy (ATP)
Function is tissue-specific and exertion-dependent — no single universal value
Energy-hungry organs are mainly affected: brain, muscle, heart, eye
In genetic forms, the link between mutation and clinical picture is often ambiguous

The established building blocks of clinical diagnostics

In evaluating possible primary mitochondrial diseases, medicine relies on a tiered combination. Biochemical markers from blood and urine are usually the first step: lactate and pyruvate (as well as their ratio), amino acids such as alanine, acylcarnitines in the blood and organic acids in the urine. A markedly elevated lactate value can be a clue — yet the Mitochondrial Medicine Society cites a sensitivity for lactate of only around 34 to 62 percent and explicitly warns against overvaluing small elevations and underestimating sampling errors.

If that is not enough, instrument-based and invasive procedures follow: exercise tests, imaging, magnetic resonance spectroscopy, and muscle biopsy with histology and measurement of respiratory chain enzyme activities (complexes I–IV). In research, oxygen utilization of isolated cells or tissue samples is additionally measured directly using high-resolution respirometry — a specialized laboratory method, not a routine or self-test. Importantly, the consensus-based standard also stresses that respiratory chain enzyme findings are not suitable as a sole criterion to rule out a mitochondrial disorder — they can come out falsely normal.

First tier: lactate/pyruvate, amino acids, acylcarnitines, organic acids in urine
Lactate sensitivity per consensus is only ~34–62 % — do not over-interpret small elevations
Further tiers: exercise test, imaging, MR spectroscopy, muscle biopsy
Muscle biopsy measures, among other things, respiratory chain enzymes; high-resolution respirometry is a research method
A normal enzyme or biopsy finding does not reliably rule out a disorder

Newer blood markers — and why they too are no universal test

In recent years, two stress messengers have drawn attention: GDF-15 and FGF-21. Both are released in greater amounts under mitochondrial stress and perform better in studies than classic markers. A systematic review (Shayota, Neurotherapeutics 2024) credits GDF-15 with "the greatest overall informativeness for mitochondrial diseases in general"; FGF-21 was statistically significant in all cohorts evaluated. Combining individual markers can improve the hit rate further.

But here too the rule holds: no marker is perfect. The reported ranges for sensitivity and specificity are broad (for GDF-15 roughly 66–98 % sensitivity, 64–97 % specificity), the measurement methods are not standardized everywhere, and secondary mitochondrial stress — that is, stress not caused by a primary mitochondrial disease — can likewise shift the values. The scientific consensus is clear: genetic (molecular) diagnostics remains the benchmark; biomarkers complement it, for instance with unclear sequencing findings, but do not replace it.

GDF-15 and FGF-21 are the most informative newer blood markers
They too have broad sensitivity/specificity ranges and inconsistent measurement methods
Secondary mitochondrial stress can shift the values non-specifically
Genetic diagnostics is the benchmark — biomarkers complement, they do not replace

Commercial mitochondria tests: an honest assessment

Direct-to-consumer offerings often advertise "mitochondrial function tests", "energy checks" or an "oxidative-stress profile" — partly from blood, partly from saliva or urine. The central weakness: there is no single, validated laboratory value that captures "mitochondrial function" of a person as an overall measure. Many of these tests measure non-specific markers (such as oxidation products or single metabolic values) whose informative value for an individual's "mitochondrial health" is not scientifically established. Markers such as malondialdehyde even performed explicitly poorly in review articles.

Added to this is the context problem: without a medical question, standardized sampling and placement within the overall clinical picture, individual values are barely interpretable. A "conspicuous" result can cause anxiety without holding diagnostic value; an "inconspicuous" one can give false reassurance. This does not mean that mitochondrial research is dubious — the clinical procedures are real and useful. It means that commercial rapid tests cannot, according to current knowledge, deliver on the claim of reliably measuring mitochondrial function.

There is no single validated laboratory value for "the" mitochondrial function
Many consumer tests measure non-specific markers with unclear individual informative value
Without a clinical question and standardization, individual values are hard to interpret
Conspicuous values can cause anxiety, inconspicuous ones give false reassurance — both without diagnostic value

What this means in practice

Anyone who suspects a metabolic or mitochondrial disease — for example because of unexplained muscle weakness, neurological symptoms or a family clustering — is far better served by a specialist, tiered evaluation than by a commercial self-test. Sound diagnostics combine medical history, biomarkers, where appropriate imaging and biopsy, as well as genetic investigations, and interpret the findings in context.

For everyone else: terms like "mitochondrial optimization" from the wellness and supplement sphere are marketing, not established diagnostics. Claims that a particular test or a particular product could measurably "repair" mitochondrial function should be read as an advertising statement and not as a proven medical fact — the human evidence for this is limited. When it comes to hormone and metabolic topics, medical evaluation remains the reliable path.

If genuinely suspected: specialist, tiered diagnostics rather than a self-test
Sound evaluation combines clinical assessment, biomarkers, where appropriate biopsy and genetics
"Mitochondrial optimization" from the wellness sphere is marketing, not diagnostics
View advertising promises about measurement or "repair" critically and as a claim

Related substance profiles

SS-31 (Elamipretid)

A cardiolipin-stabilizing mitochondrial peptide — approved in the USA for Barth syndrome in 2025.

MOTS-c

A mitochondrially encoded peptide — an "exercise mimetic" of research, not approved.

Humanin

Mitochondria-derived 24-amino-acid peptide from neuro- and longevity research — experimental, not approved.

Frequently asked questions

Can I have my mitochondrial function measured with a blood test from the internet?: Not reliably. There is no single validated laboratory value that captures mitochondrial function as an overall measure. Commercial tests mostly measure non-specific markers whose individual informative value is not established. Without a medical question and standardized sampling, individual values are barely interpretable.
Does a normal lactate value mean my mitochondria are healthy?: No. In the diagnosis of primary mitochondrial diseases, lactate has only a moderate sensitivity (according to specialist consensus around 34–62 %). A normal value does not rule out a disorder, and small elevations should not be over-interpreted. Respiratory chain enzyme findings can also come out falsely normal.
What is the benchmark in mitochondrial diagnostics today?: Genetic (molecular) diagnostics. Clinics have shifted from a "biopsy-first" to a "gene-first" approach. Biomarkers such as GDF-15 and FGF-21 and, where appropriate, a muscle biopsy complement the evaluation, but do not replace the genetic investigation.

Sources

This article is for information and education only. It does not replace medical advice and deliberately contains no dosing, usage or sourcing information.

← All guide articles